Dosimetry of a radioactive coronary balloon dilitation catheter for treatment of neointimal hyperplasia

被引:53
作者
Amols, HI
Reinstein, LE
Weinberger, J
机构
[1] SUNY STONY BROOK, DEPT RADIAT ONCOL, STONY BROOK, NY 11794 USA
[2] COLUMBIA UNIV, DEPT MED, NEW YORK, NY 10032 USA
[3] COLUMBIA UNIV, DEPT PHARMACOL, NEW YORK, NY 10032 USA
关键词
angioplasty; restenosis; brachytherapy; intracoronary irradiation; neointimal hyperplasia; beta-emitter;
D O I
10.1118/1.597761
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Recent reports suggest that intraluminal irradiation of coronary arteries in conjunction with balloon angioplasty reduces proliferation of smooth muscle cells and neointima formation, thereby inhibiting restenosis. One possible irradiation technique is to inflate the balloon dilitation catheter with a radioactive solution. This has advantages over other proposed irradiation procedures, in that accurate source positioning and uniform dose to the vessel wall are assured. Several high-energy beta-minus emitters may be suitable for this application. We present experimental measurements and analytical calculations of the dose distribution around a 3-mm-diam by 20-mm-long balloon filled with Y-90-chloride solution. The dose rate at the surface of the balloon is approximately 0.14 cGy/s per mCi/ml (3.78x10(-11) Gy/s per Bq/ml), with the dose decreasing to 53% at 0.5 mm, and <5% at 3.5-mm radial distance. Y-90 and other possible isotopes are currently available at specific concentrations greater than or equal to 50 mCi/ml (1.85x10(9) Bq/ml), which enables the delivery of 20 Gy in less than 5 min. The dosimetric and radiation safety advantages of this system warrant further feasibility studies. Issues of concern include incorporating the beta-emitter into a suitable chemical form, and assessing organ and whole body doses in the (<1 in 10(3)) event of balloon failure. (C) 1996 American Association of Physicists in Medicine.
引用
收藏
页码:1783 / 1788
页数:6
相关论文
共 26 条